Verastem, Inc. · Drugmakers

VSTM

High riskNext report: Nov 5 (confirmed)

View price ↗

The short version

A company still losing money with growing sales, with high risk. Institutions are adding.

Going well

Sales up 209% last year

Watch out for

About 12 months of cash left at its current burn
Share count growing 53.3% a year (dilution)
Losing money, losses are large next to sales

Money moves

Insiders sold $373K in the last 30 days, all through pre-planned sales
Institutions added 22% to their holdings in the quarter ending June 2026 (102 bought, 65 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$10.00-0.2% that day

Company value: $906M; Share price times all shares
Price vs sales: 10.3x; No profit over the last year, so this compares value with sales instead
Cash vs value: 15%; Cash as a share of company value

From VSTM's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$40.1M

Sep '23Tap a barJun '26

Last 12 months: $87.5M. Over 5 years, sales shrank about 19% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of VSTM. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).

Sales growth-10% a yearRecently: -19% a yearProfit margin10%Not reportedP/E at the end15xMany steady companies trade at 12x to 25xShare count change+10% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$52M

Profit in 5 years$5M

Price these guesses point to$0.53-95% vs $10.00 todayAbout -44% a year, before dividends

What today's price needs: with a 10% margin and a 15x P/E, sales would have to grow about 62% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

0/4Weak

MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.Losses many times its sales
MissProfitable every yearSteady profits, not one good year.0 of 10 years
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$137.5M
MissShare count not growingNot diluting owners. Falling means buybacks.+260.3% in 3 years

Revenue: $30.9M; +209.1% vs prior year
5-year growth: -19.0%/yr; revenue, per year
Current ratio: 3.09x; short-term assets / bills due
Free cash flow: -$137.5M; -444.8% of revenue

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+, debt under half of equity, gross margin 40%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Reported Oct 14Before open6:08 am ET

The numbers below are the quarter before. The new quarter's full numbers come with the 10-Q. Read the press release ↗

Revenue: $40.1M
EPS: -$0.35; vs -$0.62
Op. margin: -81.6%; +1966.3 pts
Free cash flow: -$43.9M
Share count: +35.2%; vs a year ago

Insider rating

Last 90 days

46Mixed

Pre-planned sales of $373K (weaker signal)

50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.

Weekly insider trend

13 weeks agoBoughtSoldThis week

Filing buzz

Last 7 days vs normal

0/ 100

This week: 0
Normal week: 1.3
vs normal: 0.0x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Accumulating+21.5%

Institutions added 21.5% to their holdings. 102 bought, 65 sold. 7 quarters of net buying in a row.

Shares held by institutions98.9M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

+53.3%

Cash runwayAt last year's cash burn

12 months

Debt to equityLatest balance sheet: debt compared with what owners have

Total liabilities $156.5M

Shares outstandingLatest reported

91M

Why high risk

Losing money, losses are large next to sales
About 12 months of cash left at its current burn
Share count growing 53.3% a year (dilution)
2 offering filings in 6 months (may sell new shares)

Earnings reports

Last 12

Next reportNov 5 (confirmed)Announced by the company in a press release ↗

Results filedOct 14
Results filedAug 6
Results filedFeb 4
Results filedNov 4, 2025
Results filedJan 13, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

Offering prospectusOct 14 · View filing ↗Offering Offering prospectusOct 14 · View filing ↗Offering 5%+ holder update (passive)Aug 14 · View filing ↗Big holder New 5%+ holder (passive)Aug 7 · View filing ↗Big holder New 5%+ holder (passive)Jul 31 · View filing ↗Big holder 5%+ holder update (passive)Jul 30 · View filing ↗Big holder

Insider trades

Open-market buys and sells, last 90 days

Bought$00 insiders

Sold$373K2 insiders, 2 pre-planned

Insider	Trade	Shares	Avg price	Value	Owns after	Date
Dan PatersonPresident and CEO	Sell	44K	$8.00	$353K	653K	Oct 1Filing ↗
-6.3% of their holdings Pre-planned sale (10b5-1) Also Director Filed 1 day after
Daniel CalkinsChief Financial Officer	Sell	3K	$8.00	$21K	124K	Oct 1Filing ↗
-2% of their holdings Pre-planned sale (10b5-1) Filed 1 day after